email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
1501 - 1515
of 3612 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Visen Pharma Closes $150 Million Financing for Endocrine Drugs
$5.00
Available
Inmagene Signs $920 Million Agreement to Acquire Four Chi-Med Immunology Therapies
$5.00
Available
BeiGene Acquires Rights to mRNA Cancer Therapy in $320 Million Deal
$5.00
Available
EOC Signs $271 Million Agreement for mTor Inhibitor from Aadi Bio
$5.00
Available
Gracell Raises $209 Million in US IPO for Novel CAR-T Therapies
$5.00
Available
Abbisko Announces $123 Million Financing for Cancer Portfolio
$5.00
Available
Zai Labs Acquires China Rights to Novel Autoimmune Drug in $175 Million Deal
$5.00
Available
APT Medical Closes $191 Million Shanghai STAR Board IPO
$5.00
Available
Keya Medical Completes $46 Million Round for AI-based Scanning Software
$5.00
Available
Everest to Start China Phase III Trial of ADC For Urothelial Cancer
$5.00
Available
Terns Completes $87 Million Financing to Advance Three NASH Candidates
$5.00
Available
Paratek Closes $60 Million Loan Using Zai Lab Royalties for Pay Off
$5.00
Available
Shanghai Pharma to Build $1.8 Billion Novel Drug Facility in Zhangjiang Park
$5.00
Available
Ocumension Invests $15.7 Million In EyePoint of the US
$5.00
Available
ImmVira Completes C Round for Oncolytic Virus and Vector Candidates
$5.00
Available